Proteomics: Applications in basic and applied biology

Current Opinion in Biotechnology

Volumn 11, Issue 4, 2000, Pages 408-412

  Anderson, N Leigh ^a   Matheson, Alastair D ^a   Steiner, Sandra ^a  

^a Large Scale Biology Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN;

DATA BASE; GENETIC ENGINEERING; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REVIEW; STRUCTURE ACTIVITY RELATION; TWO DIMENSIONAL ELECTROPHORESIS;

EID: 0033894897     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0958-1669(00)00118-X     Document Type: Review

References (37)

1. VanBogelen R.A., Schiller E.E., Thomas J.D., Neidhardt F.C. Diagnosis of cellular states of microbial organisms using proteomics. Electrophoresis. 20:1999;2149-2159.
2. VanBogelen R.A., Greis K.D., Blumenthal R.M., Tani T.H., Matthews R.G. Mapping regulatory networks in microbial cells. Trends Microbiol. 7:1999;320-328. A useful review of the combined use of proteomics and genomics to map global regulatory networks.
3. Anderson N.L., Anderson N.G. Proteome and proteomics: new technologies, new concepts, and new words. Electrophoresis. 19:1998;1853-1861.
4. Blackstock W.P., Weir M.P. Proteomics: quantitative and physical mapping of cellular proteins. Trends Biotechnol. 17:1999;121-127.
5. Vidal M., Legrain P. Yeast forward and reverse 'n'-hybrid systems. Nucleic Acids Res. 27:1999;919-929.
6. Santoni V., Rabilloud T., Doumas P., Rouquié D., Mansion M., Kieffer S., Garin J., Rossignol M. Towards the recovery of hydrophobic proteins on two-dimensional electrophoresis gels. Electrophoresis. 20:1999;705-711.
7. Molloy M.P., Herbert B.R., Williams K.L., Gooley A.A. Extraction of Escherichia coli proteins with organic solvents prior to two-dimensional electrophoresis. Electrophoresis. 20:1999;701-704.
8. Banks R.E., Dunn M.J., Forbes M.A. The potential use of laser capture microdissection to selectively obtain distinct populations of cells for proteomic analysis - preliminary findings. Electrophoresis. 20:1999;689-700.
9. Keough T., Youngquist R.S., Lacey M.P. A method for high-sensitivity peptide sequencing using postsource decay matrix-assisted laser desorption ionization mass spectrometry. Proc Natl Acad Sci USA. 96:1999;7131-7136.
10. Gygi S.P., Rist B., Gerber S.A., Turecek F., Gelb M.H., Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol. 17:1999;994-999. The authors describe a new technique that enables the relative quantities of proteins in complex mixtures to be assessed during MS-based protein characterisation.
11. Wilkins M.R., Gasteiger E., Gooley A.A., Herbert B.R., Molloy M.P., Binz P.A., Ou K., Sanchez J.C., Bairoch A., Williams K.L., Hochstrasser D.F. High-throughput mass spectrometric discovery of protein post-translational modifications. J Mol Biol. 289:1999;645-657. This paper describes the use of the FindMod database coupled to MS to rapidly identify post-translational modifications.
12. Link A.J., Eng J., Schieltz D.M., Carmack E., Mize G.J., Morris D.R., Garvik B.M., Yates J.R. III. Direct analysis of protein complexes using mass spectrometry. Nat Biotechnol. 17:1999;676-682.
13. Rigaut G., Shevchenko A., Rutz B., Wilm M., Mann M., Séraphin B. A generic protein purification method for protein complex characterization and proteome exploration. Nat Biotechnol. 17:1999;1030-1032.
14. Rubakhin S.S., Garden R.W., Fuller R.R., Sweedler J.V. Measuring the peptides in individual organelles with mass spectrometry. Nat Biotechnol. 18:2000;172-175.
15. Binz P-A., Muller M., Walther D., Bienvenut W.V., Gras R., Hoogland C., Bouchet G., Gasteiger E., Fabbretti R., Gay S.et al. A molecular scanner to automate proteomic research and to display proteome images. Anal Chem. 71:1999;4981-4988. A striking example of the levels of automation and high-throughput analysis that can now be achieved through the integration of technologies.
16. Costanzo M.C., Hogan J.D., Cusick M.E., Davis B.P., Fancher A.M., Hodges P.E., Kondu P., Lengieza C., Lew-Smith J.E., Linger C.et al. The Yeast Protein Database (YPD) and Caenorhabditis elegans Proteome Database (WormPD): comprehensive resources for the organization and comparison of model organism protein information. Nucleic Acids Res. 28:2000;73-76.
17. Langen H., Takacs B., Evers S. Two-dimensional map of the proteome of Haemophilus influenzae. Electrophoresis. 21:2000;411-429. An important addition to the array of proteomics databases currently available, with over 500 proteins identified from a total of over 1000 resolved.
18. Gauss C., Kalkum M., Lowe M., Lehrach H., Klose J. Analysis of the mouse proteome. (I) Brain proteins: separation by two-dimensional electrophoresis and identification by mass spectrometry and genetic variation. Electrophoresis. 20:1999;575-600.
19. Human 2-D PAGE Databases for Proteome Analysis in Health and Disease on World Wide Web URL: http://biobase.dk/cgi-bin/celis.
20. Klose J. Genotypes and phenotypes. Electrophoresis. 20:1999;643-652. The implications of the mouse proteome project for our understanding of the relationship between genes and proteins; proteins demonstrated to be polygenic entities with complex phenotypes.
21. Soskic V., Gorlach M., Poznanovich S., Boehmer F.D., Godovac-Zimmermann J. Functional proteomics analysis of signal transduction pathways of the platelet derived growth factor β receptor. Biochemistry. 38:1999;1757-1764.
22. Houry W.A., Frishman D., Eckerskorn C., Lottspeich F., Hartl F.U. Identification of in vivo substrates of the chaperonin GroEL. Nature. 402:1999;147-154.
23. Thiellement H., Bahrman N., Damerval C. Proteomics for genetic and physiological studies in plants. Electrophoresis. 20:1999;2013-2026.
24. Edgar P.F., Douglas J.E., Knight C., Cooper G.J., Faull R.L., Kydd R. Proteome map of the human hippocampus. Hippocampus. 9:1999;644-650.
25. Edgar P.F., Douglas J.E., Cooper G.J., Dean B., Kydd R., Faull R.L. Comparative analysis of the hippocampus implicates chromosome 6q in schizophrenia. Mol Psychiatry. 5:2000;85-90.
26. Dunn M.J. Studying heart disease using the proteomic approach. Drug Dev Therapeutics. 5:2000;76-84. A useful introductory review of the Harefield group's wide-ranging studies in cardiology.
27. Warriach R.S., Dunn M.J., Yacoub M.H. Subclass specificity of autoantibodies against myosin in patients with idiopathic dilated cardiomyopathy: pro-inflammatory antibodies in DCM patients. Biochem Biophys Res Commun. 259:1999;255-261.
28. Weekes J., Wheeler C.H., Yan J.X., Weil J., Eschenhagen T., Scholtysik G., Dunn M.J. Bovine dilated cardiomyopathy: proteomic analysis of an animal model of human dilated cardiomyopathy. Electrophoresis. 20:1999;898-906.
29. Faulk W.P., Rose M., Meroni P.L., Del Papa N., Torry R.J., Labarrere C.A., Busing K., Crisp S.J., Dunn M.J., Nelson D.R. Antibodies to endothelial cells identify myocardial damage and predict development of coronary artery disease in patients with transplanted hearts. Hum Immunol. 60:1999;826-832.
30. Celis J.E., Celis P., Ostergaard M., Basse B., Lauridsen J.B., Ratz G., Rasmussen H.H., Orntoft T.F., Hein B., Wolf H., Celis A. Proteomics and immunohistochemistry define some of the steps involved in the squamous differentiation of the bladder transitional epithelium: a novel strategy for identifying metaplastic lesions. Cancer Res. 59:1999;3000-3003. Antibodies to disease-specific proteins identified using 2DE are used to identify metaplasia and clarify the stages in its development.
31. Ostergaard M., Wolf H., Orntoft T.F., Celis J.E. Psoriacin (S100A7): a putative urinary marker for the follow-up of patients with bladder squamous cell carcinomas. Electrophoresis. 20:1999;349-354. One of the best candidates for a clinical disease marker yet produced by proteomics. This paper describes the discovery of this marker in urine of squamous cell carcinoma patients. The protein was identified earlier in keratinocytes.
32. Page M.J., Amess B., Townsend R.R., Parekh R., Herath A., Brusten L., Zvelebil M.J., Stein R.C., Waterfield M.D., Davies S.C., O'Hare M.J. Proteomic definition of normal human luminal and myoepithelial breast cells purified from reduction mammoplasties. Proc Natl Acad Sci USA. 96:1999;12589-12594. The first stage of an ongoing proteomic study of breast cancer focusing on healthy breast tissue and distinguishing individual cell types.
33. Cutler P., Bell D.J., Birrell H.C., Connelly J.C., Connor S.C., Holmes E., Mitchell B.C., Monte S.Y., Neville B.A., Pickford R.et al. An integrated proteomic approach to studying glomerular nephrotoxicity. Electrophoresis. 20:1999;3647-3658.
34. Kanitz M.H., Witzmann F.A., Zhu H., Fultz C.D., Skaggs S., Moorman W.J., Savage R.E. Jr. Alterations in rabbit kidney protein expression following lead exposure as analyzed by two-dimensional gel electrophoresis. Electrophoresis. 20:1999;2977-2985.
35. Aicher L., Wahl D., Arce A., Grenet O., Steiner S. New insights into cyclosporine A nephrotoxicity by proteome analysis. Electrophoresis. 19:1998;1998-2003.
36. Anderson N.L., Esquer-Blasco R., Richardson F., Richardson F., Foxworthy P., Eacho P. The effects of peroxisome proliferators on protein abundances in mouse liver. Toxicol Appl Pharmacol. 137:1996;75-89.
37. Giometti C.S., Tollaksen S.L., Liang X., Cunningham M.L. A comparison of liver protein changes in mice and hamsters treated with the peroxisome proliferator Wy-14,643. Electrophoresis. 19:1998;2498-2505.